| 摘要 |
<p>This invention provides 5-HT1F agonists of Formula (I) where A-B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing compounds of Formula (I) as well as methods of treating conditions associated with 5-HT1F activation employing these compounds or compositions.</p> |
